Eagle Pharmaceuticals, Inc.

Historical 13F Holders

Symbol
EGRX
CUSIP
269796108
All holders as of
Q3 2026
Type
Equity
Class
COM
Reported Value, Excluding Options
Total Shares Held, Excluding Options
Total Filers

13D/G Filers

Each filer's latest filing for 269796108 since 12/18/2024, largest first.

Filer % of Class Filed
Nantahala Capital Management, LLC 13G/A
38.1% 8/14/2025
Event 6/30/2025
Union Square Park Capital Management, LLC 13G/A
11.4% 2/14/2025
Event 12/31/2024
Nantahala Capital Partners Limited Partnership 13G
6.2% 2/19/2025
Event 2/16/2025
J. Goldman & Co LP 13G
5.1% 8/14/2025
Event 6/30/2025

13F Holders by Quarter

Period Filers Shares, Excl. Options Value, Excl. Options
2026 Q3 2 12.4 k $11.7k
2026 Q2 2 12.4 k $8.28k
2026 Q1 2 12.4 k $4.21k
2025 Q4 2 12.4 k $8.65k
2025 Q3 2 12.4 k $33.3k
2025 Q2 2 12.4 k $35.8k
2025 Q1 2 12.4 k $12.1k
2024 Q4 9 79.0 k $38.8k
2024 Q3 66 8.56 M $31.9M
2024 Q2 77 9.93 M $55.6M
2024 Q1 92 10.5 M $54.8M
2023 Q4 105 10.0 M $52.4M
2023 Q3 109 10.3 M $163M
2023 Q2 127 10.8 M $209M
2023 Q1 154 11.8 M $334M
2022 Q4 154 11.6 M $338M
2022 Q3 157 11.5 M $304M
2022 Q2 165 11.6 M $516M
2022 Q1 161 11.2 M $555M
2021 Q4 162 11.3 M $573M
2021 Q3 151 11.8 M $660M
2021 Q2 147 12.0 M $516M
2021 Q1 156 12.2 M $508M
2020 Q4 168 12.3 M $574M
2020 Q3 173 12.7 M $541M
2020 Q2 166 13.2 M $633M
2020 Q1 168 13.4 M $616M
2019 Q4 179 13.4 M $802M
2019 Q3 183 13.3 M $751M
2019 Q2 180 13.6 M $756M
2019 Q1 182 13.5 M $679M
2018 Q4 183 14.1 M $570M
2018 Q3 191 15.4 M $1.07B
2018 Q2 184 15.4 M $1.16B
2018 Q1 175 15.8 M $832M
2017 Q4 171 16.0 M $853M
2017 Q3 173 15.9 M $947M
2017 Q2 179 19.0 M $1.21B
2017 Q1 148 16.4 M $1.36B
2016 Q4 152 16.5 M $1.31B
2016 Q3 141 17.3 M $1.17B
2016 Q2 120 17.2 M $667M
2016 Q1 123 15.7 M $634M
2015 Q4 135 15.0 M $1.33B
2015 Q3 121 14.1 M $1.04B
2015 Q2 120 13.4 M $1.08B
2015 Q1 68 11.7 M $489M
2014 Q4 28 9.20 M $143M
2014 Q3 27 2.97 M $37.6M
2014 Q2 28 1.74 M $25.0M
2014 Q1 28 1.91 M $24.4M